Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:30 AM
Study NCT ID:
NCT01563302
Status:
COMPLETED
Last Update Posted:
2018-06-25
First Post:
2012-02-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-23
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-13
First Submit QC Date:
None
Study First Post Date:
2012-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-06-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-06-20
Last Update Post Date:
2018-06-25
Last Update Post Date Type:
ACTUAL